Preclinical Evidence for the Efficacy of CD79b Immunotherapy in B-cell Precursor Acute Lymphoblastic Leukemia

• Lennart Lenk,
• Dorothee Winterberg,
• Fotini Vogiatzi,
• Anna Laqua,
• Lea Spory,
• Ahmad Mayar,
• Anna Dietterle,
• Gina Münch,
• Christian Vokuhl,
• Julia Richter,
• Andrew G. Polson,
• Thomas Schüler,
• Ulf D. Kahlert,
• Matthias Peipp,
• Thomas Valerius,
• Martin Schrappe,
• Gunnar Cario,
• Hassan Jumaa,
• Elias Hobeika,
• Monika Brüggemann,
• Ameera Alsadeq,
• Denis M. Schewe

Affiliations

Lennart Lenk

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Dorothee Winterberg

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Fotini Vogiatzi

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Anna Laqua

2 Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany

Lea Spory

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Ahmad Mayar

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Anna Dietterle

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Gina Münch

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Christian Vokuhl

3 Department of Pathology, Section of Pediatric Pathology, University Hospital Bonn, Germany

Julia Richter

4 Department of Pathology, Hematopathology Section and Lymph Node Registry, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Andrew G. Polson

5 Genentech Research and Early Development, San Francisco, CA, USA

Thomas Schüler

6 Institute of Molecular and Clinical Immunology, Medical Faculty, Otto-Von-Guericke University Magdeburg, Germany

Ulf D. Kahlert

7 Molecular and Experimental Surgery, Clinic for General, Visceral, Vascular, and Transplant Surgery, Medical Faculty, University Hospital Magdeburg, Germany

Matthias Peipp

8 Department of Medicine II, Division of Antibody-Based Immunotherapy, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Thomas Valerius

9 Department of Medicine II, Section for Stem Cell Transplantation and Immunotherapy, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Martin Schrappe

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Gunnar Cario

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany

Hassan Jumaa

10 Institute of Immunology, Ulm University Medical Center, Ulm, Germany

Elias Hobeika

10 Institute of Immunology, Ulm University Medical Center, Ulm, Germany

Monika Brüggemann

2 Department of Medicine II, University Hospital Schleswig-Holstein, Kiel, Germany

Ameera Alsadeq

10 Institute of Immunology, Ulm University Medical Center, Ulm, Germany

Denis M. Schewe

1 Department of Pediatrics I, ALL-BFM Study Group, Christian-Albrechts University Kiel and University Medical Center Schleswig-Holstein, Kiel, Germany